Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A/Leningrad/134/17/57

Vaccine

Volumn 21, Issue 23, 2003, Pages 3097-3100

  Wareing, M D ^a,b   Tannock, G A ^a  

^a RMIT UNIVERSITY   (Australia)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

A Leningrad 134 17 57; IgA; Influenza A donor

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2A; INFLUENZA VACCINE;

ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CELL ASSAY; COLD ACCLIMATIZATION; DOSE CALCULATION; DRUG RESPONSE; IMMUNE RESPONSE; LUNG; MALE; MEDIASTINUM LYMPH NODE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RESPIRATORY SYSTEM; SECRETORY CELL;

EID: 0038544035     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00262-7     Document Type: Article

References (34)

1. Bruhl P., Kerschbaum A., Kistner O., Barrett N., Dorner F., Gerencer M. Humoral and cell-mediated immunity to vero cell-derived influenza vaccine. Vaccine. 19:2000;1149-1158.
2. Webster R.G., Askonas B.A. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 10:1980;396-401.
3. Blazevic V., Trubey C.M., Shearer G.M. Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses. Hum. Immunol. 61:2000;845-849.
4. Liew F.Y., Russell S.M., Appleyard G., Brand C.M., Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14:1984;350-356.
5. Mendelman P.M., Cordova J., Cho I. Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults. Vaccine. 19:2001;2221-2226.
6. Belshe R.B., Gruber W.C., Mendelman P.M.et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis. 181:2000;1133-1137.
7. Longini I.M., Halloran M.E., Nizam A.et al. Estimation of the efficacy of live, attenuated influenza vaccine from a 2-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine. 18:2000;1902-1909.
8. Belshe R.B., Gruber W.C., Mendelman P.M.et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J. Pediatr. 136:2000;168-175.
9. Khan A.S., Polezhaev F., Vasiljeva R.et al. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren. J. Infect. Dis. 173:1996;453-456.
10. Kendal A.P. Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries? Eur. J. Epidemiol. 13:1997;591-609.
11. Rudenko L.G., Slepushkin A.N., Monto A.S.et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J. Infect. Dis. 168:1993;881-887.
12. Johnson P.R., Feldman S., Thompson J.M., Mahoney J.D., Wright P.F. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J. Infect. Dis. 154:1986;121-127.
13. Clements M.L., Murphy B.R. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J. Clin. Microbiol. 23:1986;66-72.
14. Wareing M.D., Watson J.M., Brooks M.J., Tannock G.A. Immnunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice. J. Med. Virol. 65:2001;171-177.
15. Fazekas de St. Groth S., Donnelly M. Studies in experimental immunology of influenza. IV. The protective value of active immunization. Aust. J. Exp. Biol. Med. Sci. 28:1950;61-75.
16. Schulman J.E., Kilbourne E.D. Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J. Bacteriol. 89:1965;170-174.
17. Tannock G.A., Wark M.C., Smith L.E., Sutherland M.M. A clearance test in mice using non-adapted viruses to determine the immunogenicity of influenza strains. Arch. Virol. 70:1981;91-101.
18. Ben Ahmeida E.T., Jennings R., Erturk M., Potter C.W. The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus. Arch. Virol. 125:1992;71-86.
19. Justewicz D.M., Morin M.J., Robinson H.L., Webster R.G. Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin. J. Virol. 69:1995;7712-7717.
20. Tannock G.A., Paul J.A., Barry R.D. Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect. Immun. 43:1984;457-462.
21. Romanova J.R., Tannock G.A., Alexandrova G.I. Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses. Vaccine. 15:1997;653-658.
22. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science. 286:1999;2098-2102.
23. Concepts and Procedures for Laboratory-Based Influenza Surveillance, Immunology Series, vol. 6, Procedural Guide, US Department of Health and Human Services/Public Health Service/Centers for Disease Control, Section 4.2, 1982.
24. Baumgarth N., Kelso A. Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection. Eur. J. Immunol. 26:1996;2189-2197.
25. Renegar K.B., Small P.A. Jr. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65:1991;2146-2148.
26. Renegar K.B., Small P.A. Jr. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1991;1972-1978.
27. Hocart M.J., Mackenzie J.S., Stewart G.A. The IgG subclass responses to influenza virus haemagglutinin in the mouse: effect of route of inoculation. J. Gen. Virol. 70:1989;809-818.
28. Benne C.A., Harmsen M., van der Oraaff W., Verheul A.F., Snippe H., Kraaijeveld C.A. Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants. Vaccine. 15:1997;1039-1044.
29. Johnson P.R. Jr., Feldman S., Thompson J.M., Mahoney J.D., Wright P.F. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J. Med. Virol. 17:1985;325-335.
30. Jones P.D., Ada O.L. Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection. J. Virol. 60:1986;614-619.
31. Lovgren K., Kaberg H., Morein B. An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration. Clin. Exp. Immunol. 82:1990;435-439.
32. Justewicz D.M., Doherty P.C., Webster R.G. The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin. J. Virol. 69:1995;5414-5421.
33. Brokstad K.A., Cox R.J., Olofsson J., Jonsson R., Haaheim L.R. Parenteral influenza vaccination induces a rapid systemic and local immune response. J. Infect. Dis. 171:1995;198-203.
34. El-Madhun AS, Soreide A, Olofsson J, Cox RJ, Haaheim KR. Is influenza priming necessary to mount a mucosal immune response to parenteral influenza vaccination in small children? Amsterdam: Elsevier; 1996. p. 298-303.